ArticleFrontiers in public health2025
The resurgence of Lassa fever in Nigeria: economic impact, challenges, and strategic public health interventions.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Science-policy translation for Lassa fever control in West Africa: a qualitative synthesis of regional evidence.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026Article
- Temporal dynamics, climate associations, and surveillance performance of Lassa fever in Nigeria, 2020-2025: a national longitudinal analysis.Osong public health and research perspectives · 2026Article
- Evaluation of Thermal Inactivation and Chemical Disinfection Efficacy Against Lassa Virus.Viruses · 2026Article
- Impact of seasonal changes on the epidemiology of Lassa fever in a state in North Central, Nigeria.Tropical diseases, travel medicine and vaccines · 2026Article
- Strengthening health systems in lower-middle-income countries (LMICs) in Africa through the WHO Hub for emergency preparedness and outbreak response.One health outlook · 2026Review
- The persistence and mortality of Lassa fever in Nigeria reflect systemic clinical and diagnostic challenges rather than viral reemergence alone.Frontiers in epidemiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lassa fever remains a persistent public health challenge in Nigeria, with annual outbreaks expanding across the country. Between 2018 and 2023, the disease spread from 20 to 34 of Nigeria's 37 states, underscoring its endemic nature. Recent data from the Nigeria Centre for Disease Control and Prevention (NCDC) indicates 1,171 suspected cases, 290 confirmed cases, and 53 deaths between January 6 to 26, 2025, with a case fatality rate of 18.3%. Lassa fever transmission is highly seasonal, peaking during the dry months when food scarcity drives rodent-human interactions. Inadequate early detection, weak surveillance systems, and economic constraints exacerbate the burden on Nigeria's healthcare infrastructure. Environmental, socioeconomic, and systemic healthcare limitations drive the resurgence of Lassa fever. Climate change-induced shifts in temperature and precipitation patterns have disrupted rodent habitats, increasing human exposure to the virus. Additionally, poverty, poor sanitation, and urban expansion facilitate the proliferation of disease-carrying rodents. Limited funding and insufficient healthcare facilities hinder timely responses, contributing to high mortality rates. The economic impact extends beyond healthcare costs to agricultural disruptions, trade restrictions, and workforce productivity losses. To mitigate future outbreaks, Nigeria must adopt a multifaceted strategy that includes robust disease surveillance, the use of environmental data, effective rodent control measures, improved waste management, and strengthened cross-sectoral collaboration and policy implementation. Strengthening healthcare infrastructure, investing in vaccine development will enhance early detection and response efforts. By adopting an integrated One Health approach, Nigeria can improve disease control, reduce fatalities, and alleviate the economic burden of Lassa fever outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.